These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3124991

  • 1. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
    Serri O, Robert F, Comtois R, Jilwan N, Beauregard H, Hardy J, Somma M.
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
    [Abstract] [Full Text] [Related]

  • 2. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC, Chen FW, Hsieh HC.
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma.
    Kanie N, Kageyama N, Kuwayama A, Nakane T, Watanabe M, Kawaoi A.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ, Liuzzi A.
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [Abstract] [Full Text] [Related]

  • 6. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
    Lamberts SW, Zweens M, Klijn JG, van Vroonhoven CC, Stefanko SZ, Del Pozo E.
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone and prolactin in tissue culture of pituitary adenoma.
    Demura R, Kubo O, Odagiri E, Nomura K, Yamaguchi H.
    Endocrinol Jpn; 1977 Jun; 24(3):259-64. PubMed ID: 913336
    [Abstract] [Full Text] [Related]

  • 9. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T, Yoshinari M, Okamura K, Ikenoue H, Sato K, Kuroda T, Fujishima M.
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb 20; 67(2):65-74. PubMed ID: 1674920
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas.
    Serri O, Somma M, Rasio E, Brazeau P.
    Clin Endocrinol (Oxf); 1989 Jan 20; 30(1):65-75. PubMed ID: 2505955
    [Abstract] [Full Text] [Related]

  • 11. Somatomedin A increments are diminished in acromegaly with concomitant hyperprolactinaemia.
    Hulting AL, Hall K, Werner S.
    Acta Endocrinol (Copenh); 1984 Jul 20; 106(3):305-10. PubMed ID: 6429988
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone releasing factor induces prolactin secretion in acromegalic patients but not in normal subjects.
    Losa M, Schopohl J, Müller OA, von Werder K.
    Acta Endocrinol (Copenh); 1985 Aug 20; 109(4):467-73. PubMed ID: 3929513
    [Abstract] [Full Text] [Related]

  • 13. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW, Klijn JG, van Vroonhoven CC, Stefanko SZ.
    J Clin Endocrinol Metab; 1985 Jun 20; 60(6):1148-53. PubMed ID: 3923021
    [Abstract] [Full Text] [Related]

  • 14. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M, Alba-Roth J, Sobieszczyk S, Schopohl J, Müller OA, von Werder K.
    Acta Endocrinol (Copenh); 1989 Mar 20; 120(3):383-9. PubMed ID: 2494827
    [Abstract] [Full Text] [Related]

  • 15. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
    Giusti M, Lomeo A, Torre R, Sghedoni D, Mazzocchi G, Durante R, Giordano G.
    Clin Endocrinol (Oxf); 1989 Mar 20; 30(3):315-21. PubMed ID: 2574083
    [Abstract] [Full Text] [Related]

  • 16. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May 20; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 17. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1978 Dec 20; 47(6):1251-6. PubMed ID: 122426
    [Abstract] [Full Text] [Related]

  • 18. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
    Edén S, Bengtsson BA, Albertsson-Wikland K, Elfversson J, Lindstedt G, Lundberg PA, Petruson B, Rosberg S.
    Acta Endocrinol (Copenh); 1989 Jan 20; 120(1):113-20. PubMed ID: 2492135
    [Abstract] [Full Text] [Related]

  • 19. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I, Kataoka K, Tomita A, Takanohashi M, Nakane T, Kuwayama A, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan 20; 55(1):16-24. PubMed ID: 581754
    [Abstract] [Full Text] [Related]

  • 20. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
    Hofland LJ, van Koetsveld PM, Verleun TM, Lamberts SW.
    Clin Endocrinol (Oxf); 1989 Jun 20; 30(6):601-11. PubMed ID: 2512040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.